Cleared Traditional

K222528 - Well-Life Probe Electrode for Stimulati...

K222528 is the FDA 510(k) clearance for Well-Life Probe Electrode for Stimulati... by Well-Life Healthcare Limited. It is a Class 2 Gastroenterology & Urology device (product code KPI) cleared through the Traditional 510(k) pathway after a 129-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2022
Decision
129d
Days
Class 2
Risk

K222528 is an FDA 510(k) clearance for the Well-Life Probe Electrode for Stimulation/EMG Probe (Model: SA), Well-Life In.... Classified as Stimulator, Electrical, Non-implantable, For Incontinence (product code KPI), Class II - Special Controls.

Submitted by Well-Life Healthcare Limited (New Taipei City, TW). The FDA issued a Cleared decision on December 29, 2022 after a review of 129 days - within the typical 510(k) review window.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5320 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Well-Life Healthcare Limited devices

Submission Details

510(k) Number K222528 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 22, 2022
Decision Date December 29, 2022
Days to Decision 129 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1d faster than avg
Panel avg: 130d · This submission: 129d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KPI Stimulator, Electrical, Non-implantable, For Incontinence
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KPI Stimulator, Electrical, Non-implantable, For Incontinence

All 52
Devices cleared under the same product code (KPI) and FDA review panel - the closest regulatory comparables to K222528.
Unicare (K-UNICARE-USA)
K230983 · Tenscare, Ltd. · Oct 2023
MFG-05
K230780 · Zimmer Medizinsysteme GmbH · Oct 2023
Pelvic Floor Muscle Stimulator
K230767 · Nanjing Vishee Medical Technology Co., Ltd. · Sep 2023
Biofeedback Nerve and Muscle Stimulator
K220161 · Shenzhen Konmed Technology Co., Ltd. · Jul 2022
Keffort (MC-100, MC-100A)
K213133 · Oriental Inspiration Limited · Apr 2022
Everyway Incontinence Stimulation System
K213116 · Everyway Medical Instruments Co.,Ltd · Dec 2021